- Alexander, M., Upadhyay, V., Rock, R., Ramirez, L., Puchalska, P., Orellana, D., Ang, Q.Y., Turnbaugh, J.A., Tian Y., Dumlao, D., Nayak, R.R., Patterson, A., Newman, J.C, Crawford, P.A, Turnbaugh, P.J. 2023. A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity. In press Cell Reports (2024), https://doi.org/10.1016/j.celrep.2024.114891
-
Whelan, K., Alexander, M., Gaiani, C., Lunken, G., Holmes, A., Staudacher, H.M., Theis, S., Marco, M.L. Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome. 2024. Nat Microbiol 9, 2785–2794. https://doi.org/10.1038/s41564-024-01831-6
- Alexander, M., Ang, Q.Y., Nayak, R.R., Bustion, A.E., Sandy, M., Zhang, B., Upadhyay, V., Pollard, K.S., Lynch, S.V., and Turnbaugh, P.J. 2022. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host & Microbe. 30, 17 – 30.e9.
- Ang, Q.Y., Alexander, M., Newman, J.C., Tian, Y., Cai, J., Upadhyay, V., Turnbaugh, J.A., Verdin, E., Hall, K.D., Leibel, L.L., Ravussin, E., Rosenbaum, M., Patterson, A.D., and Turnbaugh, P.J. 2020. Ketogenesis alters the gut microbiome resulting in decreased intestinal Th17 levels. Cell 181, 1263-1275.E16.
- Alexander, M. and Turnbaugh, P.J. 2020. Deconstructing mechanisms of diet-microbiome-immune interactions. Immunity 53, 264-276.
- Nayak, R.R., Alexander, M., Deshpande, I., Stapleton-Gray, K., Rimal, B., Patterson, A.D., Ubeda, C., Scher, J.U., and Turnbaugh, P.J. 2021. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host & Microbe 29, 362-377.e11.
- Lam, K.N.*, Alexander, M.*, and Turnbaugh, P.J. 2019. Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host & Microbe 26, 22-34.
For a full list of publications see: